newsfilter
← Latest News
PR Newswire·

Stealth BioTherapeutics to Report Third Quarter Financial Results on Thursday, November 11

BOSTON, Nov. 4, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, toda